Perrigo | PRGO - Sales Revenues


Perrigo reported $1.11B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Abbott USD 11.16B 300M Mar/2026
Bayer EUR 11.44B 1.78B Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Coherus Biosciences USD 12.75M 1.18M Dec/2025
Corcept Therapeutics USD 202.12M 5.48M Dec/2025
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
J&J USD 24.1B 500M Mar/2026
Merck USD 16.4B 880M Dec/2025
Nestle CHF 45.26B 1.03B Dec/2025
Pacira USD 196.87M 17.35M Dec/2025
Perrigo USD 1.11B 70M Dec/2025
Pfizer USD 17.58B 880M Dec/2025
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Prestige Brands USD 283.44M 9.34M Dec/2025
Reckitt Benckiser GBP 7.26B 3.96B Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
Supernus Pharmaceuticals USD 211.6M 19.5M Dec/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025
Xeris Pharmaceuticals USD 85.81M 11.43M Dec/2025
Zoetis USD 2.4B 0 Dec/2025